SINGAPORE – Harmonization of regulations throughout the Asia Pacific region has been an ongoing goal in the past 20 years, but regulators across the region are now coming to accept that this particular goal may never be achieved. Regulators and industry stakeholders meeting in Singapore starting Tuesday for the Asia Pacific Medtech Forum 2016 said complete regional regulatory harmonization would be nice but is unlikely. While there has been some progress, a "harmonized regulatory environment will be impossible," said John Lim, deputy director of medical services at the Ministry of Health of Singapore. "If you...
SINGAPORE – Harmonization of regulations throughout the Asia Pacific region has been an ongoing goal in the past 20 years, but regulators across the region are now coming to accept that this particular goal may never be achieved.
HONG KONG – With the approval of blockbuster vaccine Prevenar 13, Pfizer Inc. is making a comeback into China’s vaccine market after being forced to shut down operations last year.
HONG KONG – With the approval of blockbuster vaccine Prevenar 13, Pfizer Inc. is making a comeback into China's vaccine market after being forced to shut down operations last year.
HONG KONG – While prominent household names like Hanmi Pharmaceutical Co. Ltd, Celltrion Inc. and Samsung Biologics Co. Ltd. seem to be hogging the global stage, inking large numbers of out-licensing deals worth billions, lesser-known South Korean drugmakers are also looking outward – just not in the same direction.
HONG KONG – While prominent household names like Hanmi Pharmaceutical Co. Ltd, Celltrion Inc. and Samsung Biologics Co. Ltd. seem to be hogging the global stage, inking large numbers of out-licensing deals worth billions, lesser-known South Korean drugmakers are also looking outward – just not in the same direction.
